(DBZN) Xtrackers - DB Bloomberg - Ratings and Ratios
Exchange: XETRA •
Country: Germany •
Currency: EUR •
Type: Etf •
ISIN: LU0429790743
Investment, Funds, Exchange-Traded, Commodities
Description: DBZN Xtrackers - DB Bloomberg
URL: http://www.dws.lu
Additional Sources for DBZN ETF
DBZN ETF Overview
| Market Cap in USD | 17m |
| Category | Commodities - Broad Basket |
| TER | 0.24% |
| IPO / Inception | 2009-07-09 |
DBZN ETF Ratings
| Growth Rating | 57.0 |
| Fundamental | - |
| Dividend Rating | 0.0 |
| Rel. Strength | 4.14 |
| Analysts | - |
| Fair Price Momentum | 20.70 EUR |
| Fair Price DCF | - |
DBZN Dividends
Currently no dividends paidDBZN Growth Ratios
| Growth Correlation 3m | 84.4% |
| Growth Correlation 12m | 80.1% |
| Growth Correlation 5y | 57.4% |
| CAGR 5y | 11.90% |
| CAGR/Max DD 5y | 0.46 |
| Sharpe Ratio 12m | 1.03 |
| Alpha | -1.02 |
| Beta | 0.286 |
| Volatility | 14.07% |
| Current Volume | 1.2k |
| Average Volume 20d | 0.5k |
What is the price of DBZN shares?
As of July 06, 2025, the stock is trading at EUR 21.46 with a total of 1,202 shares traded.
Over the past week, the price has changed by +0.33%, over one month by +1.18%, over three months by +4.21% and over the past year by +3.91%.
As of July 06, 2025, the stock is trading at EUR 21.46 with a total of 1,202 shares traded.
Over the past week, the price has changed by +0.33%, over one month by +1.18%, over three months by +4.21% and over the past year by +3.91%.
Is Xtrackers - DB Bloomberg a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, Xtrackers - DB Bloomberg (XETRA:DBZN) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 56.98 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DBZN is around 20.70 EUR . This means that DBZN is currently overvalued and has a potential downside of -3.54%.
Partly, yes. Based on ValueRay´s Analyses, Xtrackers - DB Bloomberg (XETRA:DBZN) is currently (July 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 56.98 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DBZN is around 20.70 EUR . This means that DBZN is currently overvalued and has a potential downside of -3.54%.
Is DBZN a buy, sell or hold?
Xtrackers - DB Bloomberg has no consensus analysts rating.
Xtrackers - DB Bloomberg has no consensus analysts rating.
What are the forecasts for DBZN share price target?
According to our own proprietary Forecast Model, DBZN Xtrackers - DB Bloomberg will be worth about 22.8 in July 2026. The stock is currently trading at 21.46. This means that the stock has a potential upside of +6.15%.
According to our own proprietary Forecast Model, DBZN Xtrackers - DB Bloomberg will be worth about 22.8 in July 2026. The stock is currently trading at 21.46. This means that the stock has a potential upside of +6.15%.
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 22.8 | 6.2% |